Pharmacokinetic and pharmacogenetic analysis in patients with advanced nasopharyngeal carcinoma (NPC) treated with 5-flurouracil (5-FU) and cisplatin

    Journal of Clinical Oncology, 2017.

    Cited by: 0|Bibtex|Views2|

    Abstract:

    6063 Background: Many studies have demonstrated several pharmacokinetic and pharmacogenetic factors may affect the efficacy and toxicity of 5-FU. These factors include system drug exposure (area under the concentration-time curve, AUC), thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD). This study is to investigate corre...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments